Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A viruses
Christopher L. D. McMillan(The University of Queensland), Keith J. Chappell(Australian Research Council), Geert van Amerongen(Erasmus University Rotterdam), Alberto A. Amarilla(Commonwealth Scientific and Industrial Research Organisation), Daniel Watterson(The University of Queensland), Kirsty R. Short(The University of Queensland), Helle Bielefeldt‐Ohmann(The University of Queensland), Stacey T. M. Cheung(The University of Queensland), Kate Guilfoyle(National Institute for Biological Standards and Control), Koert J. Stittelaar(Viroclinics Biosciences (Netherlands)), Patrick C. Reading(Peter Doherty Institute), Paul R. Young(Kent State University), James Barnes(Peter Doherty Institute), Leo Lee(University of Melbourne), Naphak Modhiran(The University of Queensland), Virginie Jakob, Célia Lebas
Cited by 17
Related Papers
Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome
|The Lancet|2003|1.1k
Animal models for COVID-19
|Nature|2020|877
Koch's postulates fulfilled for SARS virus
|Nature|2003|802
Back to the Future: Lessons Learned From the 1918 Influenza Pandemic
|Frontiers in Cellular and Infection Microbiology|2018|282